The CellScape™ Precise Spatial Proteomics platform is a cutting-edge imaging solution for quantitative in situ spatial phenotyping. The CellScape platform enables highly multiplexed spatial proteomics ...

GEN spoke with Milad Dagher, PhD, CEO and co-founder of Nomic, about how the nELISA platform is transforming proteomics. GEN: What are key factors influencing the broader adoption of proteomics ...

Seattle's Nautilus Biotechnology is laying off 16% of workforce, and plans to release its commercial platform in late 2026.

Shidong Wang is a leading expert in the life sciences industry, currently serving as the Associate Director of Life Sciences ...

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome-wide SAR delivering ...

Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) will likely be posting its quarterly earnings results before the market ...

Acrivon Therapeutics, Inc.’s ACRV share price has dipped by 30.24%, which has investors questioning if this is right time to ...

Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...

Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™, announces the start ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that its subsidia ...